Skip to content

Diagnostic and therapeutic pattern of acupotomy therapy for ervical spondylosis: a multicentre randomized controlled trial

A clinical multicenter evaluation study of the dominant diseases and diagnosis and treatment patterns of acupotomy therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000728
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-11-25
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylosis

Interventions

experimental group:The acupotomy was used on the 3rd to 7th cervical vertebrae the upper edge of the spinous process of the collateral ligament the articular synovial capsule the corresponding transve
control subjects:Using acupuncture treatment selected Tianzhu Daxi Liejiao Houxi as well as the pressure and pain points of the neck (1-3 points of the strongest pain) regular acupuncture after gettin

Sponsors

Affiliated Hospital of Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria for cervical spondylosis; (2) 18 years old = age = 55 years old male and female; (3) Those with negative Adson test ; (4) Pain level on neck movement score 3 = NRS = 6; (5) Those who did not use drugs and external treatments for neck discomfort in the last 1 month; (6) Willing to participate in the trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who have a combination of serious diseases (including myocardial infarction or stroke congestive heart failure severe chronic obstructive pulmonary disease liver and kidney failure and malignant tumors); (2) Those with localized skin erythema ulceration infection muscle necrosis deep tissue abscess combined with open injury; (3) Those with intracranial and extracranial organic lesions such as tumors tuberculosis infections and fracture dislocation; (4) Those with positive neck flexion test and neck rotation test; (5) Those with abnormal coagulation function and serious hematologic disorders; (6) Those with a history of shoulder and neck surgery and specific diseases of the cervical spine; (7) Pregnant and lactating women; (8) People with mental illness who cannot cooperate; (9) People who are also participating in other clinical studies; (10) Other conditions that the investigator considers inappropriate for participation in this trial.

Design outcomes

Primary

MeasureTime frame
Neck Disability Index;numerical rating scale, NRS;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index PSQI;Short Form-12;Number of cases in which the NRS score decreased by 2 points compared with before treatment;Self-Rating Anxiety Scale SAS;Expectations of Effectiveness Scale;

Countries

China

Contacts

Public ContactYang Xiaohang

Shaanxi University of Chinese Medicine

yxh1.0@163.com18691970529

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026